Analyst: US sales trends will remain negative until GTAV
Sterne Agee analyst does not foresee turnaround until Rockstar’s open-world game arrives in September, believes BioShock Infinite sold as many as 750,000 units in March.
E3 2019 Press Conference Schedule Revealed: Nintendo, Microsoft, Square Enix, And More - GS News Update Avengers: Endgame Passes Avatar in the US Box Office, Still Behind Worldwide - GS Universe News Update Game Of Thrones Series Finale Breakdown -- "The Iron Throne" Top New Games Out On Switch, PS4, Xbox One, And PC This Week -- May 19-25 2019 Pokémon Go June Community Day Announced - GS News Update More Gen 4 Pokémon, Glaceon, And Leafeon Now Available In Pokemon Go - GS News Update GS News Update: New Fortnite Battle Pass Detailed GS News Update: Star Wars: Battlefront 2 Underperforms, Microtransactions Coming Back GS News Update: Metal Gear Survive Requires Constant Internet Connection, Has Microtransactions Battlefield: Bad Company 3 Rumors Surface - GS News Roundup Red Dead Redemption 2 Mission Discovered In GTA Online?! - GS News Roundup PUBG Xbox One Performance Issues - GS News Roundup
The NPD Group will report United States industry sales tomorrow, and the results will not be pretty, nor will they turn around anytime soon. That's the opinion of Sterne Agee analyst Arvind Bhatia, who told investors today that March sales are expected to be down 10 to 15 percent.
Bhatia said BioShock Infinite is likely to be the best-selling title in March, with an estimated sellthrough in the US of 700,000 to 750,000 units on the PlayStation 3 and Xbox 360 combined. The NPD Group does not track PC software. BioShock Infinite will help publisher Take-Two Interactive see its March sales rise 70 percent year-on-year, Bhatia said.
Tomb Raider was also called out as a high-profile March title. And though the reboot enjoyed the strongest opening week in franchise history, publisher Square Enix said this title failed to live up to sales expectations.
Got a news tip or want to contact us directly? Email email@example.com